Lipella Pharmaceuticals Inc. (NASDAQ: LIPO)
$3.1700
+0.1300 ( +1.60% ) 24.3K
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
Market Data
Open
$3.1700
Previous close
$3.0400
Volume
24.3K
Market cap
$3.70M
Day range
$3.0100 - $3.2190
52 week range
$2.2100 - $12.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Oct 18, 2024 |
| 8-k | 8K-related | 13 | Sep 11, 2024 |
| 8-k | 8K-related | 13 | Aug 23, 2024 |
| 10-q | Quarterly Reports | 65 | Aug 13, 2024 |
| def | Proxies and info statements | 3 | Aug 12, 2024 |
| ars | Annual reports | 1 | Aug 12, 2024 |
| 8-k | 8K-related | 13 | Aug 06, 2024 |
| 8-k | 8K-related | 23 | Aug 01, 2024 |
| pre | Proxies and info statements | 3 | Jul 30, 2024 |
| 4 | Insider transactions | 1 | May 15, 2024 |